Enovis CORP (ENOV) SEC Filings, Dec 2025-Mar 2026

Enovis Corp Senior Vice President and Chief Financial Officer Phillip Benjamin (Ben) Berry reported a tax-related share withholding. On February 28, 2026, 720 shares of common stock at $25.47 per share were withheld by the company to cover tax obligations, leaving him with 116,009 directly owned shares. The filing states this withholding does not represent an open-market sale by Berry.

Enovis Corporation files its annual report describing a global medical technology business focused on reconstructive surgery and prevention & recovery devices. The company operates through two segments, sells broadly in the U.S. and Europe, and completed seven bolt‑on acquisitions in 2025 to expand products and distribution.

Enovis highlights extensive risks around acquisitions, leverage, regulation, reimbursement, data privacy and supply chains. It reports significant non‑cash Goodwill impairments of $501.0 million and $540.8 million in 2025 and $645.0 million in 2024 tied to declines in share price and performance at both segments. Non‑affiliate common equity had an aggregate market value of $1.91 billion as of July 4, 2025, and common shares outstanding were 57,245,131 as of February 20, 2026.

Enovis Corporation reported fourth-quarter and full-year 2025 results showing steady growth but a large accounting loss driven by goodwill impairment. Fourth-quarter net sales were $575.8 million, up 2.6%, with Reconstructive up 6.9% and Prevention & Recovery roughly flat. Adjusted EBITDA for the quarter was $111.9 million and adjusted diluted EPS was $0.95.

For 2025, net sales reached $2.248 billion, up 6.7% on a reported basis and 5.9% organically. Reconstructive grew 10%, while Prevention & Recovery grew 3.6%. The company recorded a full-year net loss from continuing operations of $1,182 million, or $20.72 per share, largely due to a non-cash goodwill impairment charge of $1,049.8 million. Adjusted EBITDA was $403.0 million and adjusted diluted EPS was $3.30.

Enovis generated $217.3 million in operating cash flow in 2025 and modestly reduced debt. For 2026, it expects revenue of $2.31–2.37 billion with 4–6% organic growth, adjusted EBITDA of $425–435 million, and adjusted EPS of $3.52–3.73.

Dimensional Fund Advisors LP filed an amended Schedule 13G reporting a passive ownership stake in Enovis Corp common stock. As of 12/31/2025, Dimensional is deemed to beneficially own 2,781,936 shares, representing 4.9 % of Enovis’s common stock. It reports sole voting power over 2,724,038 shares and sole dispositive power over 2,781,936 shares, with no shared voting or dispositive power.

The shares are actually owned by various funds and accounts it advises (the “Funds”), and Dimensional disclaims beneficial ownership, stating that all securities are owned by the Funds. Dimensional also certifies that the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Enovis.

Enovis Corporation reported that Chief Administrative Officer Oliver Engert received an equity award in the form of restricted stock units on January 5, 2026. The award covers 42,640 shares of common stock at a stated price of $0.00 per share, reflecting a grant rather than an open‑market purchase.

According to the disclosure, these restricted stock units vest in three equal annual installments, beginning on the first anniversary of the grant date. Following this award, Engert is shown as beneficially owning 42,640 shares on a direct basis.

Enovis Corp filed an initial insider ownership report for Chief Administrative Officer Oliver Engert. As of the event date of 01/05/2026, the filing states that no Enovis securities are beneficially owned, with Table I showing 0 non-derivative securities held directly and Table II showing no derivative securities listed.

Enovis Corporation filed a current report to highlight that its management team is presenting at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at 4:30 p.m. PST (7:30 p.m. EST). The company states that a live webcast of the presentation and the related slide deck will be accessible through its website at www.enovis.com, with a replay available later the same day.

The slide presentation used at the conference is also furnished as Exhibit 99.1. Enovis notes that these presentation materials are being furnished to the SEC and are not deemed incorporated by reference into its Securities Act filings.

Enovis Corp director reports stock acquisition

A director of Enovis Corp (ENOV) reported acquiring 845 shares of the company’s common stock on 12/31/2025. The transaction was reported at a price of $0.00 per share, indicating this was a form of non-cash award such as a grant. Following this transaction, the reporting person beneficially owns 22,140 shares of Enovis common stock, held in direct ownership.

Enovis Corporation reported a planned leadership transition in its human resources function. Senior Vice President and Chief Human Resources Officer Patricia A. Lang informed the board she intends to retire from her current role on April 3, 2026, then serve in an advisory position until her full retirement from the company on April 3, 2027.

Enovis expects to appoint Laura Singleton, currently Vice President of Human Resources for the Reconstructive segment, as the new Senior Vice President and Chief Human Resources Officer effective April 3, 2026. Singleton joined Enovis in 2019 through its acquisition of DJO Global and has held multiple senior HR roles, and she holds a B.A. in history from Texas State University.

The company and Ms. Lang entered into a retirement transition agreement covering the period from April 3, 2026 through April 3, 2027. During this time, she will receive her current base salary for six months, after which it may be reduced by up to 50% for the remainder of the transition period, while remaining eligible for existing benefit plans and the annual incentive plan based on her actual base pay. The full agreement will be filed with Enovis’s Form 10-K for the year ended December 31, 2025.